Searched for
ALZHEIMER OBESITY
Sleeping over 8 hours daily? Senior Neurologist at Apollo Hospitals explains its underlying health issues and potential risksAre you sleeping more than 8 hours? New research has revealed that a study of nearly 500,000 people found a 'sweet spot' of 6.4 to 7.8 hour...- These large- and mid-cap stocks can give more than 25% return in 1 year, according to analystsFor the next few weeks, what needs to be watched is market breadth. And also look at which sectors are leading the rally. Why? Because, at ...
- Eli Lilly brings monthly Alzheimer's therapy donanemab to India at ₹91,688 per vialEli Lilly is making Alzheimer's a major focus for its future innovations. The company is also expanding its specialty medicine offerings in...
- Alzheimer's a key part of Eli Lilly's India specialty medicine push, says company's country head Winselow TuckerEli Lilly has introduced Lormalzi in India, a pioneering treatment for Alzheimer's that specifically targets amyloid plaques, a significant...
- Novo Nordisk says Alzheimer's drug trial fails to meet main goalNovo Nordisk's Alzheimer's drug trials have ended without success. The semaglutide pill did not slow the brain disease's progression. This ...
- Novo Nordisk Stock Share Price Today: Why company's shares are down? Here's Alzheimer drug’s trial outcome, stock market impact, analysts insightsNovo Nordisk stock share price today fell after the company announced that semaglutide, used in Ozempic and Wegovy, failed to slow Alzheime...
- Alzheimer linked to obesity as latest research shows body fat may directly drive brain diseaseResearch study explores the link between obesity, which affects about 40 per cent of the U.S population, and the dreaded neurodegenerative ...
- Alzheimer disease symptoms treatment: Can Alzheimer's be prevented? Doctors, health experts say yes, prescribe ways to check dementiaWhat makes people more at risk of getting Alzheimer's disease and dementia more broadly? Nearly half of all cases are linked to factors suc...
- Novo Nordisk to test weight-loss drugs in broader range of obesity-linked conditionsNovo Nordisk is broadening its focus beyond obesity and diabetes by exploring the potential of its weight-loss drugs, including Wegovy, to ...
- Is sleeping too much an early sign of Alzheimer’s? Here’s what research saysScientists described their findings - published in Nature Mental Health - as a paradigm shift for understanding the connection between slee...
- GLP-1 Medications: A dual impact on health benefits and side effectsRecent study held under Dr. Ziyada Al-Aly found that GLP-1 medications can reduce the risk of disease like heart disease and addiction. The...
- Study reveals plant-based diet may reduce risk of Alzheimer's diseaseThe research identifies dietary factors influencing Alzheimer's risk, highlighting the adverse effects of saturated fats, red and processed...
- Eli Lilly's new diabetes drug could boost the stock, says SVB SecuritiesSVB Securities believes that the new diabetes drug by Eli Lilly might be able to address patients' obesity and might lead to more significa...
- High blood sugar may cause Alzheimer'sDiabetes patients have an increased risk of developing Alzheimer's disease compared to healthy individuals.
- Midlife obesity may spur risk for earlier Alzheimer'sNew research says people's weight in middle age may influence not just whether they go on to develop Alzheimer's disease, but when.
- Cardiovascular risk factors may predict Alzheimer's diseaseCardiovascular risk factors, such as alcohol consumption, smoking, obesity and diabetes may be early indicators of Alzheimer's disease.
- Healthier lifestyle could prevent Alzheimer'sMillions could be saved from developing Alzheimer's by making a few simple changes to their lifestyle, such as exercising.
- Suven to raise funds for phase II trials of Alzheimer’s moleculeSuven Life Sciences’ molecule for Alzheimer’s disease will soon enter phase II trials.
- Suven all set to raise funds for Alzheimer trialsSuven Life Sciences' molecule for Alzheimer's disease will soon enter phase two trials. Hyderabad-based contract research company is in pro...
- Suven receives two product patents associated with NeurodegenerativeSuven Life Sciences has received two product patents in Eurasia for two new chemical entities for the treatment of disorders associated wit...
Load More
